Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors (Q81460445)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 2005
edit
Language Label Description Also known as
English
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors
scientific article published on 01 November 2005

    Statements

    title
    Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    16278405
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278405%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    9 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q81460445&oldid=2153523697"